Tag Archives: Ampyra

Kyle Bass Loses Round 1 of IPR Attack Against Pharma/Biotech Patents

On August 24, 2015, the Patent Trial and Appeal Board (PTAB) declined institution of two petitions filed by Coalition For Affordable Drugs for Inter Partes Reviews (IPRs) of Acorda’s patents (U.S. Patent Nos: 8,007,826, 8,663,685) covering Ampyra, a billion-dollar drug for treating multiple sclerosis. Coalition For Affordable Drugs – Petitioner The Petitioner, Coalition For Affordable Drugs, is a … Continue reading this entry

PTAB Denies Institution of Kyle Bass IPRs -- But Not for Improper Purpose

The USPTO Patent Trial and Appeal Board (PTAB) issued it first institution decisions on IPR petitions filed by Kyle Bass and his Coalition for Affordable Drugs, denying institution of his challenges to two Orange-book listed patents for Ampyra. Many were watching to see if the PTAB would render a decision based on the “improper purpose” … Continue reading this entry